What is a breast cancer gene expression test done with?

The sample usually comes from a breast biopsy or surgery and is preserved before being sent to a specialised laboratory. The test examines patterns of gene activity in the tumour cells. Some assays use sequencing or other molecular methods to evaluate a defined group of genes.

The result can add information to the pathology report, such as how the tumour behaves and whether a person may gain useful information from particular systemic treatments. It is one part of decision-making, alongside tumour size, lymph-node findings, hormone receptors, HER2 status, overall health, and personal preferences.

Ask whether stored tissue from your biopsy or operation is suitable; a new procedure is not always needed. Your team may explain how long the laboratory process takes and which treatment decision the result is intended to inform.

When the report arrives, review the meaning with your breast cancer team. A gene expression result is not a replacement for pathology and does not confirm or exclude breast cancer on its own. It helps the team interpret an already diagnosed tumour.

The test does not usually cause a new physical symptom because it uses existing tissue. Seek prompt medical advice for a new breast change, wound redness or drainage after biopsy, fever, increasing swelling, or bleeding that does not settle.

Ask which tissue will be tested, what genes or tumour features the assay measures, which treatment choice the report may clarify, and how the result fits with your pathology findings.